Gamma Delta T Cells (GDTCs) to Eliminate Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia (CML) : A Pre-Clinical Model
Notice bibliographique
Résumé
Abstract GDTCs constitute a small subset of T-lymphocytes (<10%) involved in tumor immune surveillance and are an attractive option for adoptive immunotherapy. We are especially interested in their potential role in eliminating MRD in CML. As a first step, we determined whether or not GDTCs were part of the CML clone. 17–50 metaphases of GDTCs from each of 3 patients with documented Ph+ BCR-ABL+ CML were karyotyped and found to be Ph(−). Results were confirmed by fluorescence in situ hybridization analysis and quantitative RT-PCR for BCR-ABL. Using Miltenyi Biotec positive selection (MACS), we obtained high yield and purity of GDTCs isolated from healthy donor-derived peripheral blood mononuclear cells (PBMCs). 2.4 × 106 (± 8.6×105) GDTCs (n=13) were isolated and expanded over 1000-fold in vitro using optimized cell culture conditions. Commercial sera were screened; the chosen serum supported up to 5 times greater expansion than autologous human serum, as had been used for CML-patient-derived GDTCs. 1mg/mL concanavalin A proved the optimal mitogen, with a 2524-fold GDTC expansion compared to PHA (1764-fold) and the anti-CD3 antibody, OKT3 (267-fold). In all cases, IL-2 and IL-4 (both 10 ng/mL) supplemented culture media; neither additional IL-7 (10 ng/mL) nor IL-15 (10 ng/mL), alone or combined, improved expansion of GDTCs. The initial post-isolation purity of 97.9% (± 0.9%) as assessed by flow cytometric (FACS) analysis was maintained for culture duration. We observed that expanded GDTCs obtained from both healthy donors and Ph(+) CML patients exhibited specific cytotoxic activity against Ph+ lines, K562 and EM-2. Expanded GDTCs from Ph(+) CML patients were co-incubated with K-562 at effector:target (E:T) ratios of 1:1 and 10:1 in triplicate for 3 and 24 hours. Percent cytotoxicity, defined as % reduction in colony-forming cells (CFC) after co-incubation of GDTCs compared to CFC generated by targets alone, was comparable at both ratios: ~50% at 3 hours, decreasing to 39% at 24 hours. GDTCs isolated from 9 healthy donors were expanded in vitro and co-incubated with K562 or EM-2 at E:T of 20:1. Apoptotic cells were identified by a FACS cytotoxicity assay based on Annexin V staining. After 4 hours co-culture, K562 were 27% ± 2% and EM-2 45% ± 3% apoptotic. K562 cultured alone did not show increased Annexin V staining. Comparable results were obtained by standard chromium release assay. Simultaneous incubation of autologous PBMC with GDTCs did not yield significant PBMC Annexin V staining, confirming selective cytotoxicity of GDTCs against leukemic cells. Results were verified by incubating GDTCs from 3 healthy donors with autologous PBMCs mixed with 1.0%, 0.5%, or 0.1% K562eGFP+ cells at 20:1 E:T for 0 or 4 hours. Co-incubation with GDTCs resulted in significant and similar reduction in K562eGFP+ colonies at all ratios (96.5%, 96% and 97%, respectively). GFP-negative colony numbers were maintained after 4 hours co-incubation with GDTCs indicating specificity against K562eGFP. Similarly, GDTC co-incubation with autologous PBMCs generated 105% BFU-E and 117% CFU-GM colonies, comparing CFC generated from t=4 to t=0 hours co-culture, indicating lack of cytotoxicity against autologous committed hematopoietic progenitors. We confirmed cytotoxic efficacy of GDTCs in vitro by RT-PCR. 16 hours co-incubation of GDTCs with EM-2 resulted in a 2 log reduction in BCR-ABL transcripts. We have established a xenogeneic mouse model of CML with fluorescent and bioluminescent leukemic cells (K562eGFPluc) that we visualize via in vivo imaging system (IVIS®) technology. Both K562eGFPluc and CFSE-labelled GDTCs engraft in NODscidIL2Rg−/− mice. We are investigating cytotoxicity of GDTCs against CML MRD in this pre-clinical animal model.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,002 | 0,001 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».